[(3S)-1-[3-[3-(difluoromethyl)-1-[4-[[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]piperidin-4-yl]ethyl-methylamino]methyl]cyclohexyl]pyrazole-4-carbonyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate
C48H62F2N10O7 — CID 175860332
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S)-1-[3-[3-(difluoromethyl)-1-[4-[[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]piperidin-4-yl]ethyl-methylamino]methyl]cyclohexyl]pyrazole-4-carbonyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate
[(3S)-1-[3-[3-(difluoromethyl)-1-[4-[[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]piperidin-4-yl]ethyl-methylamino]methyl]cyclohexyl]pyrazole-4-carbonyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate (PubChem CID 175860332) has the molecular formula C48H62F2N10O7 and a molecular weight of 929.08 g/mol. Its IUPAC name is [(3S)-1-[3-[3-(difluoromethyl)-1-[4-[[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]piperidin-4-yl]ethyl-methylamino]methyl]cyclohexyl]pyrazole-4-carbonyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate.
Molecular Properties
| Compound Name | [(3S)-1-[3-[3-(difluoromethyl)-1-[4-[[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]piperidin-4-yl]ethyl-methylamino]methyl]cyclohexyl]pyrazole-4-carbonyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate |
|---|---|
| PubChem CID | 175860332 |
| Molecular Formula | C48H62F2N10O7 |
| Molecular Weight | 929.08 g/mol |
| Exact Mass | 928.48 |
| IUPAC Name | [(3S)-1-[3-[3-(difluoromethyl)-1-[4-[[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-4-methoxybenzoyl]piperidin-4-yl]ethyl-methylamino]methyl]cyclohexyl]pyrazole-4-carbonyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate |
| SMILES | COc1ccc(C(=O)N2CCC(CCN(C)CC3CCC(n4cc(C(=O)c5cnn6ccc(N7CCC[C@H](OC(=O)C(C)(C)C)C7)nc56)c(C(F)F)n4)CC3)CC2)cc1N1CCC(=O)NC1=O |
| InChI | InChI=1S/C48H62F2N10O7/c1-48(2,3)46(64)67-34-7-6-19-57(28-34)39-17-24-59-44(52-39)35(26-51-59)42(62)36-29-60(54-41(36)43(49)50)33-11-8-31(9-12-33)27-55(4)20-14-30-15-21-56(22-16-30)45(63)32-10-13-38(66-5)37(25-32)58-23-18-40(61)53-47(58)65/h10,13,17,24-26,29-31,33-34,43H,6-9,11-12,14-16,18-23,27-28H2,1-5H3,(H,53,61,65)/t31?,33?,34-/m0/s1 |
| InChIKey | LMPOMTSCLMFOBU-PHKKBQGMSA-N |
| XLogP | 6.71 |
| TPSA | 176.81 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 929.08 |
| LogP ≤ 5 | 6.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175860332 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.